ClearPoint Neuro (CLPT) Change in Receivables (2011 - 2026)

ClearPoint Neuro has disclosed Change in Receivables across 15 years of filings, most recently posting $2.0 million for Q1 2026.

• Change in Receivables for Q1 2026 came in at $2.0 million, up 338.65% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (up 159.78% YoY), and the FY2025 annual result was $268000.0, down 77.78% from the prior year.
• Change in Receivables came in at $2.0 million for Q1 2026 at ClearPoint Neuro, up from $765000.0 in the prior quarter.
• In the past five years, Change in Receivables ranged from a high of $2.0 million in Q1 2026 to a low of -$846000.0 in Q1 2024.
• The 5-year median for Change in Receivables is $401000.0 (2024), against an average of $324000.0.
• Across the five-year window, Change in Receivables soared 489.47% in 2023 and slumped 559.78% in 2024, its largest moves.
• ClearPoint Neuro's Change in Receivables stood at -$771000.0 in 2022, then soared by 248.12% to $1.1 million in 2023, then declined by 8.14% to $1.0 million in 2024, then decreased by 27.07% to $765000.0 in 2025, then jumped by 163.92% to $2.0 million in 2026.
• The last three Change in Receivables figures came in at $2.0 million (Q1 2026), $765000.0 (Q4 2025), and -$260000.0 (Q3 2025), per Business Quant data.